ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 108 filers reported holding ALBIREO PHARMA INC in Q4 2020. The put-call ratio across all filers is 2.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $23,490 | +11.6% | 1,087 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $21,044 | -2.5% | 1,087 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $21,588 | -33.4% | 1,087 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $32,425 | -69.4% | 1,087 | -76.1% | 0.00% | 0.0% |
Q4 2021 | $106,039 | -25.4% | 4,553 | 0.0% | 0.00% | -50.0% |
Q3 2021 | $142,054 | -11.3% | 4,553 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $160,175 | -0.2% | 4,553 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $160,493 | -6.0% | 4,553 | 0.0% | 0.00% | -33.3% |
Q4 2020 | $170,783 | +19.2% | 4,553 | +6.0% | 0.00% | 0.0% |
Q3 2020 | $143,324 | +26.0% | 4,295 | 0.0% | 0.00% | +50.0% |
Q2 2020 | $113,775 | +102.7% | 4,295 | +25.3% | 0.00% | +100.0% |
Q1 2020 | $56,116 | -35.6% | 3,428 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $87,140 | +30.9% | 3,428 | +3.0% | 0.00% | 0.0% |
Q3 2019 | $66,560 | -38.0% | 3,328 | 0.0% | 0.00% | -50.0% |
Q2 2019 | $107,295 | +0.1% | 3,328 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $107,195 | +31.3% | 3,328 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $81,636 | -25.6% | 3,328 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $109,691 | -99.9% | 3,328 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $118,145,000 | – | 3,328 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 480,000 | $14,318,000 | 9.25% |
Decheng Capital Management III (Cayman), LLC | 518,342 | $15,462,000 | 4.74% |
TANG CAPITAL MANAGEMENT LLC | 467,702 | $13,952,000 | 2.79% |
Birchview Capital, LP | 113,000 | $3,371,000 | 2.43% |
Privium Fund Management B.V. | 351,805 | $10,494,000 | 2.32% |
Sio Capital Management, LLC | 144,546 | $4,312,000 | 1.43% |
Perceptive Advisors | 2,360,139 | $70,403,000 | 1.41% |
Chicago Capital, LLC | 1,011,744 | $30,180,000 | 1.30% |
Endurant Capital Management LP | 120,834 | $3,604,000 | 0.95% |
Nicholas Investment Partners, LP | 439,235 | $13,102,000 | 0.93% |